» Articles » PMID: 21750418

Program-level and Contextual-level Determinants of Low-median CD4+ Cell Count in Cohorts of Persons Initiating ART in Eight Sub-Saharan African Countries

Overview
Journal AIDS
Date 2011 Jul 14
PMID 21750418
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: In sub-Saharan Africa, many patients initiate antiretroviral therapy (ART) at CD4 cell counts much lower than those recommended in national guidelines. We examined program-level and contextual-level factors associated with low median CD4 cell count at ART initiation in populations initiating ART.

Design: Multilevel analysis of aggregate and program-level service delivery data.

Methods: We examined data on 1690 cohorts of patients initiating ART during 2004-2008 in eight sub-Saharan African countries. Cohorts with median CD4 less than 111 cells/μl (the lowest quartile) were classified as having low median CD4 cell count at ART initiation. Cohort information was combined with time-updated program-level data and subnational contextual-level data, and analyzed using multilevel models.

Results: The 1690 cohorts had median CD4 cell count of 136 cells/μl and included 121,504 patients initiating ART at 267 clinics. Program-level factors associated with low cohort median CD4 cell count included urban setting [adjusted odds ratio (AOR) 2.1; 95% confidence interval (CI) 1.3-3.3], lower provider-to-patient ratio (AOR 2.2; 95% CI 1.3-4.0), no PMTCT program (AOR 3.6; 95% CI 1.0-12.8), outreach services for ART patients only vs. both pre-ART and ART patients (AOR 2.4; 95% CI 1.5-3.9), fewer vs. more adherence support services (AOR 1.6; 95% CI 1.0-2.5), and smaller cohort size (AOR 2.5; 95% CI 1.4-4.5). Contextual-level factors associated with low cohort median CD4 cell count included initiating ART in areas where a lower proportion of the population heard of AIDS, tested for HIV recently, and a higher proportion believed 'limiting themselves to one HIV-uninfected sexual partner reduces HIV risk'.

Conclusion: Determinants of CD4 cell count at ART initiation in populations initiating ART operate at multiple levels. Structural interventions targeting points upstream from ART initiation along the continuum from infection to diagnosis to care engagement are needed.

Citing Articles

Global HIV prevention, care and treatment services for children: a cross-sectional survey from the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium.

Vreeman R, Yiannoutsos C, Yusoff N, Wester C, Edmonds A, Ofner S BMJ Open. 2023; 13(3):e069399.

PMID: 36914183 PMC: 10016275. DOI: 10.1136/bmjopen-2022-069399.


Comparison of cohort characteristics in Central Africa International Epidemiology Databases to Evaluate AIDS and Demographic Health Surveys: Rwanda and Burundi.

Mageras A, Brazier E, Niyongabo T, Murenzi G, DAmour Sinayobye J, Adedimeji A Int J STD AIDS. 2021; 32(6):551-561.

PMID: 33530894 PMC: 8058267. DOI: 10.1177/0956462420983783.


Baseline CD4 and mortality trends in the South African human immunodeficiency virus programme: Analysis of routine data.

Lilian R, Rees K, Mabitsi M, McIntyre J, Struthers H, Peters R South Afr J HIV Med. 2019; 20(1):963.

PMID: 31392037 PMC: 6676982. DOI: 10.4102/sajhivmed.v20i1.963.


Late antiretroviral therapy initiation and associated factors among children on antiretroviral therapy at University of Gondar Comprehensive Specialized Hospital, Gondar, Northwest Ethiopia: a cross-sectional study.

Belay G, Engeda E, Ayele A BMC Res Notes. 2019; 12(1):255.

PMID: 31064418 PMC: 6505062. DOI: 10.1186/s13104-019-4279-z.


Trends, treatment outcomes, and determinants for attrition among adult patients in care at a large tertiary HIV clinic in Nairobi, Kenya: a 2004-2015 retrospective cohort study.

Mecha J, Kubo E, Nganga L, Muiruri P, Njagi L, Ilovi S HIV AIDS (Auckl). 2018; 10:103-114.

PMID: 29988689 PMC: 6029585. DOI: 10.2147/HIV.S153185.


References
1.
Krentz H, Auld M, Gill M . The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med. 2004; 5(2):93-8. DOI: 10.1111/j.1468-1293.2004.00193.x. View

2.
. Diagnosis and reporting of HIV and AIDS in states with HIV/AIDS surveillance--United States, 1994-2000. MMWR Morb Mortal Wkly Rep. 2002; 51(27):595-8. View

3.
Laurent C, Diakhate N, Ngom Gueye N, Toure M, Sow P, Faye M . The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS. 2002; 16(10):1363-70. DOI: 10.1097/00002030-200207050-00008. View

4.
Lawn S, Myer L, Orrell C, Bekker L, Wood R . Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS. 2005; 19(18):2141-8. DOI: 10.1097/01.aids.0000194802.89540.e1. View

5.
Torpey K, Lartey M, Amenyah R, Addo N, Obeng-Baah J, Rahman Y . Initiating antiretroviral treatment in a resource-constrained setting: does clinical staging effectively identify patients in need?. Int J STD AIDS. 2009; 20(6):395-8. DOI: 10.1258/ijsa.2008.008333. View